Target intelligence / Profile preview

Intestinal smooth muscle contraction

Molecular classification
Other
01

Overview

Intestinal smooth muscle contraction," often referred to as **peristalsis**, is not a single molecular target but rather a complex physiological process involving the coordinated activity of multiple cell types and signaling pathways within the gastrointestinal tract. Peristalsis consists of rhythmic contractions and relaxations of circular and longitudinal smooth muscle layers that propel food and waste through the intestines[3][5][7]. This process is regulated by several mechanisms: - **Pacemaker cells** known as interstitial cells of Cajal (ICC) generate slow-wave electrical activity that sets the basic rhythm for contractions[1][4]. - **Smooth muscle cells** contract in response to depolarization triggered by calcium influx through voltage-dependent calcium channels[1][2]. - The **enteric nervous system** coordinates local reflexes; excitatory neurotransmitters like acetylcholine and substance P stimulate contraction above a bolus, while inhibitory neurotransmitters such as nitric oxide and vasoactive intestinal peptide promote relaxation below it[3][5]. Peristaltic function can be modulated by drugs acting on various receptors or ion channels involved in these pathways—such as muscarinic acetylcholine receptors (notably M2/M3 subtypes)[8], L-type calcium channels, or serotonin receptors—but "intestinal smooth muscle contraction/peristalsis" itself does not represent a discrete druggable entity like an enzyme or receptor. Because this entry refers to a broad physiological process rather than a specific molecule or receptor, it is considered incorrect as a canonical therapeutic target. Instead, individual molecular components involved in this process—such as muscarinic acetylcholine receptor M3 or L-type calcium channel—should be specified when discussing drug targets. If you are seeking structured information about specific molecules mediating intestinal peristalsis (e.g., "Muscarinic acetylcholine receptor M3"), please specify which component you wish to focus on.

Other names
PeristalsisGastrointestinal motilityIntestinal peristalsisGut motility
02

Biological functions

Propulsion of intestinal contentsDigestionAbsorption facilitation
03

Disease associations

Gastrointestinal motility disordersIrritable bowel syndrome (IBS)Chronic constipationDiarrhea-predominant conditions

Beyond the preview

Go deeper on Intestinal smooth muscle contraction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal smooth muscle contraction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call